Veriheal
JANUARY 24, 2023
But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. After receiving a petition three years prior, the DEA finally answered with action, making plans to deschedule [18F]FP-CIT , a controlled substance derived from cocaine.
Veriheal
MAY 6, 2022
If so, you can consider yourself among the 50%-85% of adults who battle the occasional nightmare during REM sleep. The Sleep Foundation suggests that nightmares in children are most common between the ages of 3 and 6 but usually occur less often with age. The good news is that cannabis could be the tool for a good night’s sleep.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Freedom Leaf
OCTOBER 15, 2018
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.
FloridaMarijuana.net
JULY 8, 2018
The study has received full approval from the FDA, DEA, and Institutional Review Boards (IRBs). Patients suffering from the symptoms of PTSD (depression, anxiety, sleep disorders, mood disorders) will find Blue Dream to offer mood-boosting relief. PTSD can affect all facets of life including sleep. Pineapple Express.
CannaMD
AUGUST 8, 2020
Cannabinoids (natural and plant-derived) interact with endocannabinoid receptors to regulate appetite, sleep, pain, stress, and more. For example, the DEA considers Schedule I drugs to have a “high potential for abuse and the potential to create severe psychological and/or physical dependence.” CBD Scheduling Rule Change.
MedicalJane
JUNE 29, 2018
The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. The Next Move Is On The DEA.
Cannabis Law Report
JANUARY 28, 2022
Marijuana myths continue to keep people from trying medical marijuana as a treatment. A lot of people think it just gets you high, but for many, it is actually a treatment that provides relief and not just a euphoric high,” she said. “I Marijuana Myths Continue to Hinder What Marijuana Can Do. It’s not.”.
Expert insights. Personalized for you.
98 
Let's personalize your content